On the other hand, in the US, where most of those personnel are, stock transactions are private. We’d have no way of knowing, unless the person just decided to volunteer the information.
I can imagine it might not be within ethical standards to trade in a company when one is involved in trial administration. Not that it would happen, but consider someone shorting a company and then sabotaging a trial or conversely, going long and then manipulating the data to appear more favorable.
- Forums
- ASX - By Stock
- KZA
- Ann: Paxalisib receives Fast Track Designation from US FDA
Ann: Paxalisib receives Fast Track Designation from US FDA, page-40
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)